(2023)
The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.
FRONTIERS IN ONCOLOGY.
13,
(2022)
Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?.
JOURNAL OF CLINICAL MEDICINE.
11,
21
(2022)
Factors Affecting Pathologic Complete Remission in Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy.
ONCOLOGY.
100,
10
(2021)
Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer.
EJSO.
47,
2
(2020)
Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model.
IN VIVO.
34,
6
(2020)
Oral Methioninase Inhibits Recurrence in a PDOX Mouse Model of Aggressive Triple-negative Breast Cancer.
IN VIVO.
34,
5
(2020)
Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients.
NUTRIENTS.
12,
9
(2020)
A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model.
ANTICANCER RESEARCH.
40,
5
